Announcing the Intent To Award a Single-Source Supplement for the Advancing Person-Centered, Trauma-Informed Supportive Services for Holocaust Survivors Program, 18309-18310 [2018-08708]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
BILLING CODE 4120–01–P
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
amozie on DSK30RV082PROD with NOTICES
Information Collection
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Skilled Nursing
Facility and Skilled Nursing Facility
Cost Report; Use: Providers of services
participating in the Medicare program
are required under sections 1815(a),
1833(e) and 1861(v)(1)(A) of the Social
Security Act (42 U.S.C. 1395g) to submit
annual information to achieve
settlement of costs for health care
services rendered to Medicare
beneficiaries. In addition, regulations at
42 CFR 413.20 and 413.24 require
adequate cost data and cost reports from
providers on an annual basis. The Form
CMS–2540–10 cost report is needed to
determine a provider’s reasonable cost
incurred in furnishing medical services
to Medicare beneficiaries and
reimbursement due to or from a
provider. Reimbursement outside of the
PPS may be for payment of Medicare
reimbursable bad debt. Form Number:
CMS–2540–10 (OMB control number:
0938–0463); Frequency: Yearly; Affected
Public: Private Sector; Not-for-profit
institutions, Businesses or other forprofits; Number of Respondents: 14,486;
Total Annual Responses: 14,486; Total
Annual Hours: 2,926,172. (For policy
16:58 Apr 25, 2018
Jkt 244001
Dated: April 20, 2018.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2018–08723 Filed 4–25–18; 8:45 am]
CMS–2540–10 Skilled Nursing
Facility and Skilled Nursing Facility
Cost Report
VerDate Sep<11>2014
questions regarding this collection
contact Julie Stankivic at 410–786–
5725.)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Announcing the Intent To Award a
Single-Source Supplement for the
Advancing Person-Centered, TraumaInformed Supportive Services for
Holocaust Survivors Program
The Administration for Community
Living (ACL) announces the intent to
award a single-source supplement to the
current cooperative agreement held by
the Jewish Federations of North
America for the project Advancing
Person-Centered, Trauma-Informed
Supportive Services for Holocaust
Survivors. The purpose of this project is
to, (1) advance the development and
expansion of person-centered, traumainformed (PCTI) supportive services for
Holocaust survivors living in the U.S.
and, (2) improve the nation’s overall
capacity to deliver PCTI health and
human services for this population and
to any older adult with a history of
trauma. The administrative supplement
for FY 2018 will be in the amount of
$2,467,000, bringing the total award for
FY 2018 to $4,935,000.
The additional funding will not be
used to begin new projects, but to serve
more Holocaust survivors with vital
supports such as legal assistance, case
management, transportation, medication
management, social engagement
activities designed to reduce isolation,
loneliness and depression, and supports
for family caregivers, all of which will
employ PCTI approaches. The
additional funds will also be used to
expand existing technical assistance
activities, under the second objective, in
a variety of ways, including replicating
and translating proven models of PCTI
developed under this grant; developing
new training materials, curricula and
partnerships to aid in the replication of
PCTI practices; enhance and expand the
evaluation activities currently under
way; and enhance website capacities for
improved information dissemination.
Program Name: Advancing PersonCentered, Trauma-Informed (PCTI)
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
18309
Supportive Services for Holocaust
Survivors.
Recipient: The Jewish Federations of
North America.
Period of Performance: The
supplement award will be issued for the
fourth year of the five-year project
period of September 30, 2015 through
September 29, 2020.
Total Award Amount: $4,935,000 in
FY 2018.
Award Type: Cooperative Agreement
Supplement.
Statutory Authority: The Older
Americans Act (OAA) of 1965, as
amended, Public Law 109–365—Title 4,
Section 411.
Basis for Award: The Jewish
Federations of North America (JFNA) is
currently funded to carry out the
objectives of this project, entitled
Advancing PCTI Supportive Services for
Holocaust Survivors for the period of
September 30, 2015 through September
29, 2020. Since project implementation
began in late 2015, the grantee has
accomplished a great deal. The
supplement will enable the grantee to
carry their work even further, serving
more Holocaust survivors and providing
even more comprehensive training and
technical assistance in the development
of PCTI supportive services. The
additional funding will not be used to
begin new projects or activities.
The JFNA is uniquely positioned to
complete the work called for under this
project. JFNA and its project partners,
including the Network of Jewish Human
Services Agencies (NJHSA), and the
Conference on Material Claims Against
Germany (Claims Conference), have the
cultural competence and long history of
serving and advocating for Holocaust
survivors. Additionally, JFNA is already
working in collaboration with numerous
partners representing a broad cross
section of the Jewish human services
network (e.g., Selfhelp Community
Services, Bet Tzedek, The Blue Card,
and the Orthodox Union of America)
and the ‘‘mainstream aging services
network,’’ (e.g., Meals on Wheels of
America (MoWA), the National
Association of Area Agencies on Aging
(n4a), the National Council on Aging
(NCOA), Leading Age and other
members of the Leadership Council of
Aging Organizations [LCAO]).
Establishing an entirely new grant
project at this time would be potentially
disruptive to the current work already
well under way. More importantly, the
Holocaust survivors currently being
served by this project could be
negatively impacted by a service
disruption, thus posing the risk of retraumatization and further negative
impacts on health and wellbeing. If this
E:\FR\FM\26APN1.SGM
26APN1
18310
Federal Register / Vol. 83, No. 81 / Thursday, April 26, 2018 / Notices
supplement were not provided, the
project would be less able to address the
significant unmet needs of additional
Holocaust survivors. Similarly, the
project would be unable to expand its
current technical assistance and training
efforts in PCTI concepts and
approaches, let alone reach beyond
traditional providers of services to this
population to train more ‘‘mainstream’’
providers of aging services.
For More Information Contact: For
further information or comments
regarding this program supplement,
contact Greg Link, U.S. Department of
Health and Human Services,
Administration for Community Living,
Administration on Aging, Office of
Supportive and Caregiver Services:
telephone (202)–795–7386; email
greg.link@acl.hhs.gov.
Dated: April 18, 2018.
Mary Lazare,
Principal Deputy Administrator.
[FR Doc. 2018–08708 Filed 4–25–18; 8:45 am]
BILLING CODE 4154–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–1489]
Vaccines and Related Biological
Products Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Vaccines and Related
Biological Products Advisory
Committee (VRBPAC). The general
function of the committee is to provide
advice and recommendations to the
Agency on FDA’s regulatory issues. At
least one portion of the meeting will be
closed to the public.
DATES: The meeting will be held on May
17, 2018, from 8 a.m. to 4:45 p.m.
ADDRESSES: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm.
amozie on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:58 Apr 25, 2018
Jkt 244001
For those unable to attend in person,
the meeting will also be webcast and
will be available at the following link:
https://collaboration.fda.gov/
vrbpac2018/.
FOR FURTHER INFORMATION CONTACT:
Serina Hunter-Thomas or Rosanna
Harvey, Center for Biologics Evaluation
and Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 71, Rm. 6338, Silver Spring,
MD 20993–0002, 240–402–5771,
serina.hunter-thomas@fda.hhs.gov and
240–402–8072, rosanna.harvey@
fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
announced advisory committee meeting
cannot always be published quickly
enough to provide timely notice.
Therefore, you should always check the
Agency’s website at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
SUPPLEMENTARY INFORMATION:
Agenda: On May 17, 2018, under
Topic I, the Center for Biologics
Evaluation and Research’s (CBER)
VRBPAC will meet in open session to
discuss approaches for demonstrating
effectiveness of group B streptococcus
(GBS) vaccines intended for use in
pregnant women to protect the newborn
infant. Also on May 17, 2018, under
Topic II, the committee will meet in
open session to hear an overview of the
research program in the Laboratory of
Respiratory Viral Diseases (LRVD),
Division of Viral Products, Office of
Vaccines Research and Review, CBER,
FDA.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its website prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s website after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: On May 17, 2018, from 8
a.m. to 4:10 p.m., the meeting is open
to the public. Interested persons may
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before May 10, 2018. Oral
presentations from the public will be
scheduled between approximately 12:35
p.m. to 1:20 p.m. for the GBS vaccine
portion of the meeting, and 3:50 p.m. to
4:05 p.m. for the overview portion of the
LRVD Site Visit. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before May 2,
2018. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by May 3, 2018.
Closed Committee Deliberations: On
May 17, 2018, from 4:10 p.m. to 4:45
p.m., the meeting will be closed to
permit discussion where disclosure
would constitute a clearly unwarranted
invasion of personal privacy (5 U.S.C.
552b(c)(6)). The recommendations of the
advisory committee regarding the
progress of the investigator’s research
will, along with other information, be
used in making personnel and staffing
decisions regarding individual
scientists.
We believe that public discussion of
these recommendations on individual
scientists would constitute an
unwarranted invasion of personal
privacy.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require accommodations due to a
disability, please contact Serina HunterThomas at least 7 days in advance of the
meeting (see, FOR FURTHER INFORMATION
CONTACT).
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our website at:
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
E:\FR\FM\26APN1.SGM
26APN1
]]>Agencies
[Federal Register Volume 83, Number 81 (Thursday, April 26, 2018)]
[Notices]
[Pages 18309-18310]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Announcing the Intent To Award a Single-Source Supplement for the
Advancing Person-Centered, Trauma-Informed Supportive Services for
Holocaust Survivors Program
The Administration for Community Living (ACL) announces the intent
to award a single-source supplement to the current cooperative
agreement held by the Jewish Federations of North America for the
project Advancing Person-Centered, Trauma-Informed Supportive Services
for Holocaust Survivors. The purpose of this project is to, (1) advance
the development and expansion of person-centered, trauma-informed
(PCTI) supportive services for Holocaust survivors living in the U.S.
and, (2) improve the nation's overall capacity to deliver PCTI health
and human services for this population and to any older adult with a
history of trauma. The administrative supplement for FY 2018 will be in
the amount of $2,467,000, bringing the total award for FY 2018 to
$4,935,000.
The additional funding will not be used to begin new projects, but
to serve more Holocaust survivors with vital supports such as legal
assistance, case management, transportation, medication management,
social engagement activities designed to reduce isolation, loneliness
and depression, and supports for family caregivers, all of which will
employ PCTI approaches. The additional funds will also be used to
expand existing technical assistance activities, under the second
objective, in a variety of ways, including replicating and translating
proven models of PCTI developed under this grant; developing new
training materials, curricula and partnerships to aid in the
replication of PCTI practices; enhance and expand the evaluation
activities currently under way; and enhance website capacities for
improved information dissemination.
Program Name: Advancing Person-Centered, Trauma-Informed (PCTI)
Supportive Services for Holocaust Survivors.
Recipient: The Jewish Federations of North America.
Period of Performance: The supplement award will be issued for the
fourth year of the five-year project period of September 30, 2015
through September 29, 2020.
Total Award Amount: $4,935,000 in FY 2018.
Award Type: Cooperative Agreement Supplement.
Statutory Authority: The Older Americans Act (OAA) of 1965, as
amended, Public Law 109-365--Title 4, Section 411.
Basis for Award: The Jewish Federations of North America (JFNA) is
currently funded to carry out the objectives of this project, entitled
Advancing PCTI Supportive Services for Holocaust Survivors for the
period of September 30, 2015 through September 29, 2020. Since project
implementation began in late 2015, the grantee has accomplished a great
deal. The supplement will enable the grantee to carry their work even
further, serving more Holocaust survivors and providing even more
comprehensive training and technical assistance in the development of
PCTI supportive services. The additional funding will not be used to
begin new projects or activities.
The JFNA is uniquely positioned to complete the work called for
under this project. JFNA and its project partners, including the
Network of Jewish Human Services Agencies (NJHSA), and the Conference
on Material Claims Against Germany (Claims Conference), have the
cultural competence and long history of serving and advocating for
Holocaust survivors. Additionally, JFNA is already working in
collaboration with numerous partners representing a broad cross section
of the Jewish human services network (e.g., Selfhelp Community
Services, Bet Tzedek, The Blue Card, and the Orthodox Union of America)
and the ``mainstream aging services network,'' (e.g., Meals on Wheels
of America (MoWA), the National Association of Area Agencies on Aging
(n4a), the National Council on Aging (NCOA), Leading Age and other
members of the Leadership Council of Aging Organizations [LCAO]).
Establishing an entirely new grant project at this time would be
potentially disruptive to the current work already well under way. More
importantly, the Holocaust survivors currently being served by this
project could be negatively impacted by a service disruption, thus
posing the risk of re-traumatization and further negative impacts on
health and wellbeing. If this
[[Page 18310]]
supplement were not provided, the project would be less able to address
the significant unmet needs of additional Holocaust survivors.
Similarly, the project would be unable to expand its current technical
assistance and training efforts in PCTI concepts and approaches, let
alone reach beyond traditional providers of services to this population
to train more ``mainstream'' providers of aging services.
For More Information Contact: For further information or comments
regarding this program supplement, contact Greg Link, U.S. Department
of Health and Human Services, Administration for Community Living,
Administration on Aging, Office of Supportive and Caregiver Services:
telephone (202)-795-7386; email [email protected].
Dated: April 18, 2018.
Mary Lazare,
Principal Deputy Administrator.
[FR Doc. 2018-08708 Filed 4-25-18; 8:45 am]
BILLING CODE 4154-01-P
